Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directorate changes

16th Dec 2019 07:01

RNS Number : 9505W
Chemring Group PLC
16 December 2019
 

FOR IMMEDIATE RELEASE 16 DECEMBER 2019

 

 

CHEMRING GROUP PLC ("Chemring" or the "Company")

 DIRECTORATE CHANGES

Chemring today announces the following directorate changes.

 

Nigel Young, who has served as a non-executive director for nearly seven years, has indicated his intention to retire on 30 April 2020, when his current appointment comes to an end.

 

Andrew Davies, Chairman of Chemring's Remuneration Committee, will be stepping down as Chairman of the Remuneration Committee following the Company's Annual General Meeting in March 2020 and will be succeeded by Laurie Bowen. Andrew Davies will remain a member of the Remuneration Committee.

 

 

-ENDS-

 

For further information:

 

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

Andrew Jaques MHP Communications 020 3128 8100

Oliver Hughes

 

 

Notes to editors

 

·; Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

·; Employing approximately 2,500 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

·; Chemring is now organised under two strategic product segments: Sensors & Information and Countermeasures & Energetics

·; Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

·; Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOAGMMMZVVVGLZG

Related Shares:

Chemring
FTSE 100 Latest
Value8,809.74
Change53.53